Throughout my life, I have been fascinated with how the brain mediates higher cognitive function. I am particularly interested in understanding how population activity between neurons and local networks leads to changes in information processing and behavior. My graduate and post-doctoral research aimed to decipher the principles behind population coding in visual cortical circuits, with a strong emphasis on how population codes are modified by sensory experience and how population coding influences behavior. I am now the Director of Data Science and Digital Health-Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson. My responsibilities include leading the digital health strategy for the neurodegeneration portfolio. My goals are to identify clinically meaningful digital biomarkers from biosensors, smartphones, and different types of active and passive data streams to obtain more objective, more continuous about patients and their disease state. There are limitless possibilities to impact the field of neuroscience when you combine digital health technologies with sophisticated data science approaches. Always to improve the lives of patients, caregivers, and their families.